000			01470nam a2200385Ia 4500
001			EBC3017947
003			MiAaPQ
005			20240121041549.0
006			m o d |
007			cr cn|||||||||
008			120802s2012 nyua sb 001 0 eng d
010			_z 2012418415
020			_z9781619423435
020			_a9781619423459 (electronic bk.)
035			_a(MiAaPQ)EBC3017947
035			_a(Au-PeEL)EBL3017947
035			_a(CaPaEBR)ebr10654918
035			_a(OCoLC)828140625
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRM405.5 _b.I54 2012
245	0	0	_aInfliximab _h[electronic resource] : _bpharmacology, uses and limitations / _cAntonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors.
260			_aNew York : _bNova Science Publishers, _cc2012.
300			_axiv, 188 p. : _bill.
490	0		_aImmunology and immune system disorders
504			_aIncludes bibliographical references and index.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aAnti-inflammatory agents.
650		0	_aInfliximab _xTherapeutic use.
650		0	_aInfliximab.
655		4	_aElectronic books.
700	1		_aFajardo Gaitan, Montserrat.
700	1		_aMedrano Acevedo, Antonio D.
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3017947 _zClick to View
999			_c150903 _d150903